bullish

Sequent Scientific - Recovery in API Business; Gross Margin Remains Below FY21

199 Views30 May 2022 09:09
Broker
Sequent Scientific’s (SSL) 4QFY22 revenue at Rs3,837mn was broadly in line with our estimate. However, EBITDA and net profit declined by 8% QoQ and 48% QoQ, respectively.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 14-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Nirmal Bang
A Relationship Beyond Broking
IndiaEquity Bottom-UpThematic (Sector/Industry)
  • Sequent Scientific - Recovery in API Business; Gross Margin Remains Below FY21
    30 May 2022
x